These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 2908137)

  • 41. Dopamine D2 receptor agents, but not dopamine D1, modify brain glucose metabolism.
    Palacios JM; Wiederhold KH
    Brain Res; 1985 Feb; 327(1-2):390-4. PubMed ID: 3157422
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Behavioural expression of D-1 receptor supersensitivity depends on previous stimulation of D-2 receptors.
    Morelli M; Fenu S; Di Chiara G
    Life Sci; 1987 Jan; 40(3):245-51. PubMed ID: 2948094
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Potency and efficacy of dopamine agonists in mouse strains differing in dopamine cell and receptor number.
    Shannon HE; Bemis KG; Peters SC
    Pharmacol Biochem Behav; 1991 Sep; 40(1):103-7. PubMed ID: 1685781
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Stimulation of both dopamine D1 and D2 receptors facilitates in vivo acetylcholine release in the hippocampus.
    Imperato A; Obinu MC; Gessa GL
    Brain Res; 1993 Aug; 618(2):341-5. PubMed ID: 8104086
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Release-regulating D-2 dopamine receptors are located on striatal glutamatergic nerve terminals.
    Maura G; Giardi A; Raiteri M
    J Pharmacol Exp Ther; 1988 Nov; 247(2):680-4. PubMed ID: 2903237
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Behavioral effects of chronic exposure to selective D-1 and D-2 dopamine receptor agonists.
    Braun AR; Chase TN
    Eur J Pharmacol; 1988 Mar; 147(3):441-51. PubMed ID: 3259931
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Vasomotor responses of cerebral arterioles in situ to putative dopamine receptor agonists.
    Edvinsson L; McCulloch J; Sharkey J
    Br J Pharmacol; 1985 Jun; 85(2):403-10. PubMed ID: 3896363
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Differential effects of pallidal lesions on the behavioural responses to SKF 38393, LY 171555 and apomorphine in the rat.
    Fletcher GH; Starr MS
    Neuroscience; 1989; 28(1):171-80. PubMed ID: 2569694
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pharmacological characterization of dopamine receptors in the stellate ganglia with selective DA1 and DA2 receptor agonists and antagonists.
    Sabouni MH; Alkadhi KA; Lokhandwala MF
    J Pharmacol Exp Ther; 1986 Jan; 236(1):65-70. PubMed ID: 2867216
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Presynaptic autoinhibition of the electrically evoked dopamine release studied in the rat olfactory tubercle by in vivo electrochemistry.
    Suaud-Chagny MF; Ponec J; Gonon F
    Neuroscience; 1991; 45(3):641-52. PubMed ID: 1775239
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of D1 and D2 antagonists on the transient increase of dopamine release by dopamine agonists by means of brain dialysis.
    Kurata K; Shibata R
    Neurosci Lett; 1991 Nov; 133(1):77-80. PubMed ID: 1686482
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of the D1 receptor agonist SKF 38393 on some behavioural effects of apomorphine in rats.
    Zarkovsky AM; Cereska KS
    Naunyn Schmiedebergs Arch Pharmacol; 1989 Apr; 339(4):383-6. PubMed ID: 2567965
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Inhibition of low calcium induced epileptiform discharges in the hippocampus by dopamine D1 receptor agonist, SKF 38393.
    Smiałowski A
    Brain Res; 1990 Sep; 528(1):148-50. PubMed ID: 2147120
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Ontogeny of locomotor activity and grooming in the young rat: role of dopamine D1 and D2 receptors.
    McDougall SA; Arnold TF; Nonneman AJ
    Eur J Pharmacol; 1990 Sep; 186(2-3):223-30. PubMed ID: 1981185
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Repeated administration of SCH 23390 enhances the SKF 38393-induced inhibition in the rat hippocampus.
    Smiałowski A; Bijak M
    Neuroscience; 1989; 28(2):409-12. PubMed ID: 2564173
    [TBL] [Abstract][Full Text] [Related]  

  • 56. D-1 dopamine receptors and arousal.
    Ongini E
    Adv Exp Med Biol; 1988; 235():169-78. PubMed ID: 2976250
    [No Abstract]   [Full Text] [Related]  

  • 57. SKF 38393 potentiates yawning induced by LY 171555: further evidence against the autoreceptor hypothesis of yawning.
    Spina L; Longoni R; Mulas A; Di Chiara G
    Psychopharmacology (Berl); 1989; 98(4):567-8. PubMed ID: 2570436
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Biphasic effect of locally applied apomorphine and 2,3,4,5-tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine on the release of striatal dopamine investigated by means of brain dialysis.
    Kurata K; Shibata R
    Neurosci Lett; 1990 Sep; 117(3):264-8. PubMed ID: 1982738
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Repeated treatment with imipramine enhances the excitatory response of hippocampal neurons to dopamine.
    Smiałowski A; Bijak M
    Neuroscience; 1987 Dec; 23(3):1021-4. PubMed ID: 2963971
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Acute effects of lithium on dopaminergic responses: iontophoretic studies in the rat visual cortex.
    Gottberg E; Montreuil B; Reader TA
    Synapse; 1988; 2(4):442-9. PubMed ID: 2903566
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.